CN103251605B - Myriberine A在制备治疗乳腺癌药物中的应用 - Google Patents
Myriberine A在制备治疗乳腺癌药物中的应用 Download PDFInfo
- Publication number
- CN103251605B CN103251605B CN201310217779.8A CN201310217779A CN103251605B CN 103251605 B CN103251605 B CN 103251605B CN 201310217779 A CN201310217779 A CN 201310217779A CN 103251605 B CN103251605 B CN 103251605B
- Authority
- CN
- China
- Prior art keywords
- breast cancer
- myriberine
- myriberinea
- preparation treatment
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310217779.8A CN103251605B (zh) | 2013-06-03 | 2013-06-03 | Myriberine A在制备治疗乳腺癌药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310217779.8A CN103251605B (zh) | 2013-06-03 | 2013-06-03 | Myriberine A在制备治疗乳腺癌药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103251605A CN103251605A (zh) | 2013-08-21 |
CN103251605B true CN103251605B (zh) | 2016-05-04 |
Family
ID=48956040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310217779.8A Expired - Fee Related CN103251605B (zh) | 2013-06-03 | 2013-06-03 | Myriberine A在制备治疗乳腺癌药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103251605B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105496990A (zh) * | 2016-02-02 | 2016-04-20 | 南京正亮医药科技有限公司 | Heyneanones A在制备治疗乳腺癌药物中的应用 |
CN105663121A (zh) * | 2016-02-02 | 2016-06-15 | 南京正亮医药科技有限公司 | Aogacillin B在制备治疗乳腺癌药物中的应用 |
-
2013
- 2013-06-03 CN CN201310217779.8A patent/CN103251605B/zh not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
Myriberine A, a New Alkaloid with an Unprecedented Heteropentacyclic Skeleton from Myrioneuron faberi;Sheng-Dian Huang,et al.;《ORGANIC LETTERS》;20130115;第15卷(第3期);第590-593页 * |
生物碱的药理作用及机制研究;柏云娇等;《哈尔滨商业大学学报(自然科学版)》;20130228;第29卷(第1期);第8-11页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103251605A (zh) | 2013-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103251605B (zh) | Myriberine A在制备治疗乳腺癌药物中的应用 | |
CN102861099B (zh) | Houttuynoid D在制备治疗子宫内膜癌药物中的应用 | |
CN102872142B (zh) | Houttuynoid D在制备治疗卵巢癌药物中的应用 | |
CN102861080B (zh) | Houttuynoid C在制备治疗鼻咽癌药物中的应用 | |
CN102872085B (zh) | Houttuynoid A在治疗乳腺癌药物中的应用 | |
CN103479630B (zh) | Lycojaponicumin A在制备治疗乳腺癌药物中的应用 | |
CN103405418A (zh) | Chukrasone B在治疗乳腺癌药物中的应用 | |
CN103462969B (zh) | Incarviatone A在制备治疗乳腺癌药物中的应用 | |
CN103463069B (zh) | Lycojaponicumin C在制备治疗鼻咽癌药物中的应用 | |
CN102861079B (zh) | Houttuynoid B在制备治疗皮肤癌药物中的应用 | |
CN102872110B (zh) | Houttuynoid D在制备治疗乳腺癌药物中的应用 | |
CN103479633B (zh) | Lycojaponicumin B在制备治疗鼻咽癌药物中的应用 | |
CN102872072B (zh) | Houttuynoid B在治疗肾癌药物中的应用 | |
CN103463061B (zh) | Lycojaponicumin C在制备治疗前列腺癌药物中的应用 | |
CN102872135B (zh) | Houttuynoid D在治疗肾癌药物中的应用 | |
CN103446089B (zh) | Incarviatone A在制备治疗鼻咽癌药物中的应用 | |
CN103446146B (zh) | Lycojaponicumin C在制备治疗回盲肠癌药物中的应用 | |
CN102861074B (zh) | Houttuynoid B在制备治疗膀胱癌药物中的应用 | |
CN102872074B (zh) | Houttuynoid C在治疗肾癌药物中的应用 | |
CN103462960A (zh) | Incarviatone A在治疗前列腺癌药物中的应用 | |
CN102872103B (zh) | Houttuynoid E在治疗鼻咽癌药物中的应用 | |
CN102872109B (zh) | Houttuynoid A在制备治疗前列腺癌药物中的应用 | |
CN102872075A (zh) | Houttuynoid E在治疗乳腺癌药物中的应用 | |
CN105596334A (zh) | Leuconoxine在制备治疗乳腺癌药物中的应用 | |
CN105395536A (zh) | Flabelliferin A在制备治疗回盲肠癌药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Wu Kaidong Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160407 Address after: 273399 No. 235 Lianhua Road, Pingyi County, Shandong, Linyi Applicant after: Wu Kaidong Address before: Gu Tan Road Economic Development Zone in Gaochun District of Nanjing City, Jiangsu province 211300 branch No. 3 Building Room 607 Applicant before: Nanjing Zhengliang Medical Technology Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160504 Termination date: 20170603 |
|
CF01 | Termination of patent right due to non-payment of annual fee |